Progression‐free survival is a weakly predictive surrogate end‐point for overall survival in follicular lymphoma: A systematic review and meta‐analysis

Documenti analoghi

• Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades
  di: M. Alzahrani, et al.
  Pubblicazione: (2025)
• Loncastuximab tesirine elicits complete responses in secondary central nervous system lymphoma
  di: Adam J. Olszewski, et al.
  Pubblicazione: (2025)
• The role of imaging studies in predicting time to first treatment and overall survival in high‐count monoclonal B‐cell lymphocytosis
  di: Samuel Kosydar, et al.
  Pubblicazione: (2025)
• The value of semiquantitative PET features and end‐of‐therapy PET in grade 3B follicular lymphoma
  di: Allison Barraclough, et al.
  Pubblicazione: (2024)
• Treating asymptomatic follicular lymphoma: What is the score?
  di: Ghassan Zammar, et al.
  Pubblicazione: (2024)